Long-term outcomes after induction chemotherapy with docetaxel, cisplatin and 5-FU (TPF) followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal cancer.

被引：0
|
作者：
Cho, Sang-Hee
Shim, Hyun-Jeong
Hwang, Jun-Eul
Bae, Woo Kyun
Chung, Ik-Joo
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Hemato Oncol, Hwasun, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
[3] Chonnam Natl Univ, Hwasun Hosp, Dept Med Oncol, Hwasun, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18008
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase Ⅱ study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Yuan Wu
    Xueyan Wei
    Zilong Yuan
    Hongbin Xu
    Yanping Li
    Ying Li
    Liu Hu
    Guang Han
    Yu Qian
    Desheng Hu
    Chinese Journal of Cancer Research, 2020, 32 (05) : 665 - 672
  • [22] RESULTS OF NEOADJUVANT CHEMORADIOTHERAPY WITH DOCETAXEL AND 5-FU FOLLOWED BY ESOPHAGECTOMY FOR LOCALLY ADVANCED ESOPHAGEAL CANCER
    Hamai, Y.
    Hihara, J.
    Aoki, Y.
    Emi, M.
    Okada, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 251 - 251
  • [23] Neoadjuvant Therapy in locally advanced Oral cancer: Chemotherapy induction with Docetaxel/Cisplatin/5-FU followed by concurrent radiation therapy plus Docetaxel/Cisplatin followed by Surgery - Phase I Study: Results and 3J-FU
    Grehl, S.
    Eberhardt, W.
    Poettgen, C.
    Abu Jawad, J.
    Kaelberlah, H. -P
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 90 - 90
  • [24] The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Zhou, R.
    Zhu, J.
    Chen, X.
    Liu, Y.
    Wang, Y.
    Zhang, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 429 - 439
  • [25] The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    R. Zhou
    J. Zhu
    X. Chen
    Y. Liu
    Y. Wang
    T. Zhang
    Clinical and Translational Oncology, 2020, 22 : 429 - 439
  • [26] Preliminary report of induction chemotherapy with Docetaxel, Cisplatin, 5FU (TPF) in the treatment of locally advanced Head and Neck cancer
    Kehagioglou, P.
    Ioannidou, G.
    Xesfyngi, D.
    Lagogiannis, G.
    Stavrinidis, I.
    Papala, K.
    Papadogiorgakis, N.
    Katsilieris, I.
    ONKOLOGIE, 2010, 33 : 127 - 127
  • [27] INDUCTION CHEMOTHERAPY (CT) WITH DOCETAXEL, CISPLATIN, AND FLUOROURACIL (TPF) FOLLOWED BY CONCOMITANT CISPLATIN PLUS RADIOTHERAPY IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER (NPC) RESULTS AFTER 03 YEARS
    Kerboua, E.
    Lagha, N.
    Arab, A.
    Chami, S.
    Mekki, F.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 344 - 345
  • [28] Induction chemotherapy (CT) with docetaxel, cisplatin, and fluorouracil (TPF) followed by concomitant cisplatin plus radiotherapy in locally advanced nasopharyngeal cancer (NPC): Results after 06 years
    Kerboua, Esma
    Bouzid, Kamel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Comparison of neoadjuvant Chemoradiotherapy with Docetaxel/Cisplatin/5-FU or Cisplatin alone in locally-advanced Oral cancer
    Abu Jawad, J.
    Grehl, S.
    Poettgen, C.
    Pfoertner, R.
    Eberhardt, W.
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 100 - 100
  • [30] Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation versus concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori, R
    Tsukuda, M
    Ishitoya, J
    Kimura, M
    Hirose, S
    Takahashi, M
    Sakuma, Y
    Yamamoto, K
    Satoh, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 519S - 519S
12345